Finance

Lists
ACUTAAS:NSE
Acutaas Chemicals Ltd
₹3,166.60
-0.20%
(-6.40) 1D
Aug 25, 10:50:37 AM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ACUTAAS...
Open
₹3,189.90
High
₹3,217.50
Low
₹3,138.00
Mkt. cap
259.25B
Avg. vol.
0.00
Volume
73.65K
P/E ratio
67.37
52-wk high
₹3,740.00
52-wk low
₹1,302.00
EPS
₹47.00
No. of employees
879
Open
₹3,189.90
High
₹3,217.50
Low
₹3,138.00
Mkt. cap
259.25B
Avg. vol.
0.00
Volume
73.65K
P/E ratio
67.37
52-wk high
₹3,740.00
52-wk low
₹1,302.00
EPS
₹47.00
No. of employees
879
News stories
From web sources and news partners
About Acutaas Chemicals Ltd
CEO-
Employees879
Founded2007
Headquarters-
SectorPharmaceutical industry
Last report
Jul 24, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
₹9.04 / ₹9.57
-5.51%miss
Revenue / Est. (INR)
3.30B / 3.30B
-0.13%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.06B
3.93B
4.33B
3.30B
Cost of goods sold
1.35B
1.69B
1.64B
1.39B
Cost of revenue
1.35B
1.69B
1.64B
1.39B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
293.53M
298.57M
332.89M
395.67M
Operating expense
838.23M
831.79M
944.29M
876.67M
Total operating expenses
2.19B
2.52B
2.59B
2.26B
Operating income
869.21M
1.41B
1.74B
1.03B
Other non operating income
98.37M
46.99M
111.11M
18.01M
EBT including unusual items
961.80M
1.45B
1.84B
1.04B
EBT excluding unusual items
961.80M
1.45B
1.84B
1.04B
Income tax expense
243.24M
384.49M
495.18M
289.17M
Effective tax rate
25.29%
26.58%
26.94%
27.83%
Other operating expenses
460.68M
434.98M
515.10M
382.79M
Net income
722.41M
1.08B
1.32B
742.60M
Net profit margin
23.59%
27.46%
30.45%
22.53%
Earnings per share
8.82
13.10
16.04
9.04
Interest and investment income
-
-
-
-
Interest expense
-5.79M
-8.61M
-11.90M
-11.41M
Net interest expenses
-5.79M
-8.61M
-11.90M
-11.41M
Depreciation and amortization charges
84.02M
98.25M
96.30M
98.21M
EBITDA
951.87M
1.47B
1.83B
1.12B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps